See also this year's filing and all EDGAR filings for this company.
PDF Report 0001600132_2021_Bellerophon_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001600132')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001600132, Bellerophon Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 48,080,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 169,000 |
| 3 | remainder_Assets | 1,990,000 |
| 4 | LiabilitiesCurrent | 10,433,000 |
| 5 | LiabilitiesNoncurrent | 956,000 |
| 6 | remainder_Liabilities | 601,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,386,000 |
| 9 | ResearchAndDevelopmentExpense | 17,890,000 |
| 10 | remainder_Expenses | -1,798,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -250,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 50,239,000 |
| 1 | Liabilities | 11,990,000 |
| 2 | Expenses | 24,478,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 38,249,000 |
| 5 | NetIncome | -24,728,000 |
| 6 | ComprehensiveNetIncome | -24,728,000 |
| 7 | BaseVar | 43,478,500 |
| 8 | EconomicCapitalRatio | 1.32 |
Edgar->Model Mapping
Feature Distribution
Change over Time
